What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

The analysts expect launches of medicines including Eli Lilly’s Zepbound and Novo Nordisk ... HF market share if they offer a novel mechanism of action, enhanced clinical profiles or help ...

Anti-obesity drug Mounjaro is set rack up sales of nearly £22bn a year by 2030. But Trump's 'America First' policies mean Britons could soon be paying more for the 'King Kong' of weight-loss jabs ...

Mounjaro: Also contains tirzepatide and shares the same mechanism of action as Zepbound. It is branded for the treatment of Type 2 diabetes but is essentially the same compound as Zepbound.

As current weight loss medications like Ozempic, Wegovy, and Zepbound face persistent supply ... insights into how PGC-1α orchestrates the mechanisms that control how energy is consumed at ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s biotech market.

the approval of COBENFY marks a transformative milestone as the first drug in over 30 years with a novel mechanism of action for treating schizophrenia. Combining xanomeline and trospium ...

Both semaglutide (such as Ozempic) and tirzepatide (such as Zepbound and Mounjaro ... reductions in body weight due to its dual-action mechanism. Cost and availability: Tirzepatide is newer ...